A single-center, retrospective study analysing effect of ruxolitinib-containing treatment for patients with lymphoma-associated hemophagocytic syndrome
Latest Information Update: 22 Oct 2020
At a glance
- Drugs Dexamethasone (Primary) ; Doxorubicin (Primary) ; Etoposide (Primary) ; Ruxolitinib (Primary)
- Indications Haemophagocytic lymphohistiocytosis
- Focus Therapeutic Use
- 01 Nov 2020 Results published in the Journal of Cancer Research and Clinical Oncology
- 22 Oct 2020 New trial record